funding

Main funding awards and grants received, in reverse chronological order.

2025

  1. NVIDIA Academic Grant Program: Generative AI / Simulation & Modeling

    2025.07 - 2025.12

    NVIDIA Academic Grant Program, United Kingdom

    Co-Investigator

    • Selected for the NVIDIA Academic Grant Program, which provides world-class computing resources (cloud, hardware, and/or software) to advance academic research in generative AI and simulation & modeling.
    • The grant supports research on cardiac whole-heart volumetric mesh reconstruction and generation based on Graph Gaussian Splatting (GGS), aiming to enhance the high-fidelity modeling of cardiac anatomical structures in simulation-ready format.
    • Funding: £50k.

  2. UK CEiRSI— The UK's Centre of Excellence on In-silico Regulatory Science and Innovation - Pilot Phase (10139527)

    2025.02 - 2026.01

    MRC-InnovateUK, United Kingdom

    Contributor to Pilot 3: Virtual Populations for Transcatheter Aortic Valve Implantation (TAVI) Device Regulation

    • The UK Centre of Excellence on in-silico Regulatory Science and Innovation (UK CEiRSI) addresses a critical deadlock in medical product development and regulation. While Computational Modelling and Simulation (CM&S) techniques offer potential for more reliable, faster, and cost-effective medical product testing and approvals, their adoption is hindered by a regulatory-industrial impasse: regulators lack evidence to accept in-silico methods as alternatives to live trials, while developers hesitate to invest without regulatory assurance. Building on successful preliminary work in international partnerships and regulatory guidance, the project will implement an innovative In-Silico Regulatory Airlock Initiative. Through pre-competitive pilot case studies of hypothetical medical products, the initiative will evaluate and refine existing credibility frameworks (including FDA and ASME V&V standards) to establish robust UK principles for regulatory adoption of in-silico technologies, ultimately aiming to transform the medical product development landscape.
    • The University of Manchester, University of Oxford, University College London, Queen Mary University of London, University of Birmingham, University of Edinburgh, University of Liverpool, University of Sheffield, University of Strathclyde, Swansea University, University of York. The partnership extends to key industry stakeholders, including ANSYS UK, the Association of British HealthTech Industries, BioNow, Edwards Lifesciences, Health Innovation Research Alliance, Health Innovation Manchester, Medtronic, NAFEMS, NHS England, NPL, The British Standards Institution, and The Organisation for Professionals in Regulatory Affairs.
    • Funding: £1m.

2019

  1. INSILEX: Precision Computational Medicine for in silico Trials of Medical Devices (CiET1819/19)

    2019.05 - 2029.04

    Royal Academy of Engineering, United Kingdom

    Research Contributor and Project Management Contributor in Year 6

    • The Academy's Chair in Emerging Technologies scheme aims to identify global research visionaries and provide them with long-term support to lead on developing emerging technology areas with high potential to deliver economic and social benefit to the UK.
    • Funding: £2.69m.